NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes
Abstract Background Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for regenerative medicine and in drugs screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes and are still imma...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02264-2 |
id |
doaj-eba6cf288f574778b4d2afc7481472c6 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xinyuan Zhang Liang Ye Hao Xu Qin Zhou Bin Tan Qin Yi Liang Yan Min Xie Yin Zhang Jie Tian Jing Zhu |
spellingShingle |
Xinyuan Zhang Liang Ye Hao Xu Qin Zhou Bin Tan Qin Yi Liang Yan Min Xie Yin Zhang Jie Tian Jing Zhu NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes Stem Cell Research & Therapy Nuclear factor erythroid 2 p45-related factor 2 (NRF2) Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) Metabolism |
author_facet |
Xinyuan Zhang Liang Ye Hao Xu Qin Zhou Bin Tan Qin Yi Liang Yan Min Xie Yin Zhang Jie Tian Jing Zhu |
author_sort |
Xinyuan Zhang |
title |
NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes |
title_short |
NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes |
title_full |
NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes |
title_fullStr |
NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes |
title_full_unstemmed |
NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes |
title_sort |
nrf2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes |
publisher |
BMC |
series |
Stem Cell Research & Therapy |
issn |
1757-6512 |
publishDate |
2021-03-01 |
description |
Abstract Background Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for regenerative medicine and in drugs screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes and are still immature; these cells mainly rely on glucose as a substrate for metabolic energy, while mature cardiomyocytes mainly employ oxidative phosphorylation of fatty acids. Studies showed that the alteration of metabolism pattern from glycolysis to oxidative phosphorylation improve the maturity of hiPSC-CMs. As a transcription factor, accumulating evidences showed the important role of NRF2 in the regulation of energy metabolism, which directly regulates the expression of mitochondrial respiratory complexes. Therefore, we hypothesized that NRF2 is involved in the maturation of hiPSC-CMs. Methods The morphological and functional changes related to mitochondria and cell maturation were analyzed by knock-down and activation of NRF2. Results The results showed that the inhibition of NRF2 led to the retardation of cell maturation. The activation of NRF2 leads to a more mature hiPSC-CMs phenotype, as indicated by the increase of cardiac maturation markers, sarcomere length, calcium transient dynamics, the number and fusion events of mitochondria, and mitochondrial respiration. Bioinformatics analysis showed that in addition to metabolism-related genes, NRF2 also activates the expression of myocardial ion channels. Conclusions These findings indicated that NRF2 plays an important role in the maturation of hiPSC-CMs. The present work provides greater insights into the molecular regulation of hiPSC-CMs metabolism and theoretical basis in drug screening, disease modeling, and alternative treatment. |
topic |
Nuclear factor erythroid 2 p45-related factor 2 (NRF2) Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) Metabolism |
url |
https://doi.org/10.1186/s13287-021-02264-2 |
work_keys_str_mv |
AT xinyuanzhang nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT liangye nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT haoxu nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT qinzhou nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT bintan nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT qinyi nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT liangyan nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT minxie nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT yinzhang nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT jietian nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes AT jingzhu nrf2isrequiredforstructuralandmetabolicmaturationofhumaninducedpluripotentstemcellderivedardiomyocytes |
_version_ |
1724200433571856384 |
spelling |
doaj-eba6cf288f574778b4d2afc7481472c62021-03-28T11:09:23ZengBMCStem Cell Research & Therapy1757-65122021-03-0112111510.1186/s13287-021-02264-2NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytesXinyuan Zhang0Liang Ye1Hao Xu2Qin Zhou3Bin Tan4Qin Yi5Liang Yan6Min Xie7Yin Zhang8Jie Tian9Jing Zhu10Department of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityChongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityChongqing Key Laboratory of PediatricsDepartment of Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child development and Critical Disorders, Children’s Hospital of Chongqing Medical UniversityAbstract Background Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great promise for regenerative medicine and in drugs screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes and are still immature; these cells mainly rely on glucose as a substrate for metabolic energy, while mature cardiomyocytes mainly employ oxidative phosphorylation of fatty acids. Studies showed that the alteration of metabolism pattern from glycolysis to oxidative phosphorylation improve the maturity of hiPSC-CMs. As a transcription factor, accumulating evidences showed the important role of NRF2 in the regulation of energy metabolism, which directly regulates the expression of mitochondrial respiratory complexes. Therefore, we hypothesized that NRF2 is involved in the maturation of hiPSC-CMs. Methods The morphological and functional changes related to mitochondria and cell maturation were analyzed by knock-down and activation of NRF2. Results The results showed that the inhibition of NRF2 led to the retardation of cell maturation. The activation of NRF2 leads to a more mature hiPSC-CMs phenotype, as indicated by the increase of cardiac maturation markers, sarcomere length, calcium transient dynamics, the number and fusion events of mitochondria, and mitochondrial respiration. Bioinformatics analysis showed that in addition to metabolism-related genes, NRF2 also activates the expression of myocardial ion channels. Conclusions These findings indicated that NRF2 plays an important role in the maturation of hiPSC-CMs. The present work provides greater insights into the molecular regulation of hiPSC-CMs metabolism and theoretical basis in drug screening, disease modeling, and alternative treatment.https://doi.org/10.1186/s13287-021-02264-2Nuclear factor erythroid 2 p45-related factor 2 (NRF2)Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)Metabolism |